Gemfibrozil
- Product NDC
- 68071-4421
- 11-digit product format
- 680714421
- Labeler code
- 68071
- Product ID
- 68071-4421_6bb40362-ff8c-4c3e-e053-2a91aa0ab66a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Gemfibrozil
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA203266
- Marketing category
- ANDA
- Marketing start
- 2017-02-15
- Marketing end
- 0000-00-00
- Substance
- GEMFIBROZIL
- Active strength
- 600 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68071-4421-3 | 2020-06-15 | C162847 | 48780-1 | 9d75b9d1-0162-f424-e053-dadaa90a57ce | 6bb3fe14-6676-6925-e053-2991aa0a099b |
| 68071-4421-6 | 2020-06-15 | C162847 | 48780-1 | 9d75b9d1-0162-f424-e053-dadaa90a57ce | 6bb3fe14-6676-6925-e053-2991aa0a099b |
| 68071-4421-8 | 2020-06-15 | C162847 | 48780-1 | 9d75b9d1-0162-f424-e053-dadaa90a57ce | 6bb3fe14-6676-6925-e053-2991aa0a099b |
| 68071-4421-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0162-f424-e053-dadaa90a57ce | 6bb3fe14-6676-6925-e053-2991aa0a099b |
| 68071-4421-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0162-f424-e053-dadaa90a57ce | 6bb3fe14-6676-6925-e053-2991aa0a099b |
| 68071-4421-8 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-0162-f424-e053-dadaa90a57ce | 6bb3fe14-6676-6925-e053-2991aa0a099b |